Exhaled breath condensate adenosine tracks lung function changes in cystic fibrosis

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 304, Issue 7, 2013, Pages

  Esther, Charles R ^a   Olsen, Bonnie M ^a   Lin, Feng Chang ^b   Fine, Jason ^b   Boucher, Richard C ^c  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Purinergic; Quality of life; Spirometry; Sputum

Indexed keywords

ADENOSINE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; PHENYLALANINE; UREA; BIOLOGICAL MARKER; IL8 PROTEIN, HUMAN; PANCREATIC ELASTASE;

ARTICLE; CHILD; EXPIRED AIR; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FIBROSIS; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; QUALITY OF LIFE; SPUTUM ANALYSIS; ADOLESCENT; ADULT; CLINICAL TRIAL; CYSTIC FIBROSIS; LUNG FUNCTION TEST; METABOLISM; SPUTUM;

ADENOSINE; ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CYSTIC FIBROSIS; FEMALE; HUMANS; INTERLEUKIN-8; MALE; PANCREATIC ELASTASE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SPUTUM; UREA;

MLCS; MLOWN;

EID: 84878241840     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00344.2012     Document Type: Article

References (42)

1. Alexis NE, Hu SC, Zeman K, Alter T, Bennett WD. Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med 164: 1964-1970, 2001.
2. Armstrong DS, Grimwood K, Carlin JB, Carzino R, Gutièrrez JP, Hull J, Olinsky A, Phelan EM, Robertson CF, Phelan PD. Lower airway inflammation in infants and young children with cystic fibrosis. Am J Respir Crit Care Med 156: 1197-1204, 1997.
3. Armstrong DS, Hook SM, Jamsen KM, Nixon GM, Carzino R, Carlin JB, Robertson CF, Grimwood K. Lower airway inflammation in infants with cystic fibrosis detected by newborn screening. Pediatr Pulmonol 40: 500-510, 2005.
4. Bodini A, D'Orazio C, Peroni D, Corradi M, Folesani G, Baraldi E, Assael BM, Boner A, Piacentini GL. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections. Pediatr Pulmonol 40: 494-499, 2005.
5. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, Insel PA, Junger WG. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 314: 1792-1795, 2006.
6. Colombo C, Costantini D, Rocchi A, Cariani L, Garlaschi ML, Tirelli S, Calori G, Copreni E, Conese M. Cytokine levels in sputum of cystic fibrosis patients before and after antibiotic therapy. Pediatr Pulmonol 40: 15-21, 2005.
7. Csoma Z, Huszar E, Vizi E, Vass G, Szabo Z, Herjavecz I, Kollai M, Horvath I. Adenosine level in exhaled breath increases during exerciseinduced bronchoconstriction. Eur Respir J 25: 873-878, 2005.
8. Davis SD, Fordham LA, Brody AS, Noah TL, Retsch-Bogart GZ, Qaqish BF, Yankaskas BC, Johnson RC, Leigh MW. Computed tomography reflects lower airway inflammation and tracks changes in early cystic fibrosis. Am J Respir Crit Care Med 175: 943-950, 2007.
9. Demko CA, Byard PJ, Davis PB. Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection. J Clin Epidemiol 48: 1041-1049, 1995.
10. Driver AG, Kukoly CA, Ali S, Mustafa SJ. Adenosine in bronchoalveolar lavage fluid in asthma. Am Rev Respir Dis 148: 91-97, 1993.
11. Effros RM, Biller J, Foss B, Hoagland K, Dunning MB, Castillo D, Bosbous M, Sun F, Shaker R. A simple method for estimating respiratory solute dilution in exhaled breath condensates. Am J Respir Crit Care Med 168: 1500-1505, 2003.
12. Effros RM, Dunning III, MB, Biller J, Shaker R. The promise and perils of exhaled breath condensates. Am J Physiol Lung Cell Mol Physiol 287: L1073-L1080, 2004.
13. Effros RM, Hoagland KW, Bosbous M, Castillo D, Foss B, Dunning M, Gare M, Lin W, Sun F. Dilution of respiratory solutes in exhaled condensates. Am J Respir Crit Care Med 165: 663-669, 2002.
14. Esther CR Jr, Alexis NE, Clas ML, Lazarowski ER, Donaldson SH, Ribeiro CM, Moore CG, Davis SD, Boucher RC. Extracellular purines are biomarkers of neutrophilic airway inflammation. Eur Respir J 31: 949-956, 2008.
15. Esther CR Jr, Boysen G, Olsen BM, Collins LB, Ghio AJ, Swenberg JW, Boucher RC. Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 296: L987-L993, 2009.
16. Esther CR Jr, Jasin HM, Collins LB, Swenberg JA, Boysen G. A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate. Rapid Commun Mass Spectrom 22: 701-705, 2008.
17. Esther CR Jr, Lazaar AL, Bordonali E, Qaqish B, Boucher RC. Elevated airway purines in chronic obstructive pulmonary disease. Chest 140: 954-960, 2011.
18. Fujita J, Nelson NL, Daughton DM, Dobry CA, Spurzem JR, Irino S, Rennard SI. Evaluation of elastase and antielastase balance in patients with chronic bronchitis and pulmonary emphysema. Am Rev Respir Dis 142: 57-62, 1990.
19. Gaber F, Acevedo F, Delin I, Sundblad BM, Palmberg L, Larsson K, Kumlin M, Dahlen SE. Saliva is one likely source of leukotriene B4 in exhaled breath condensate. Eur Respir J 28: 1229-1235, 2006.
20. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 159: 179-187, 1999.
21. Ho SA, Ball R, Morrison LJ, Brownlee KG, Conway SP. Clinical value of obtaining sputum and cough swab samples following inhaled hypertonic saline in children with cystic fibrosis. Pediatr Pulmonol 38: 82-87, 2004.
22. Hunt J. Exhaled breath condensate: an evolving tool for noninvasive evaluation of lung disease. J Allergy Clin Immunol 110: 28-34, 2002.
23. Huszar E, Vass G, Vizi E, Csoma Z, Barat E, Molnar Vilagos G, Herjavecz I, Horvath I. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma. Eur Respir J 20: 1393-1398, 2002.
24. Ichikawa T, Matsunaga K, Minakata Y, Yanagisawa S, Ueshima K, Akamatsu K, Hirano T, Nakanishi M, Sugiura H, Yamagata T, Ichinose M. Possible impact of salivary influence on cytokine analysis in exhaled breath condensate. Anal Chem Insights 2: 85-92, 2007.
25. Idzko M, Hammad H, van Nimwegen M, Kool M, Willart MAM, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F, Virchow JC, Lambrecht BN. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nat Med 13: 913-919, 2007.
26. Johnson GR, Morawska L. The mechanism of breath aerosol formation. J Aerosol Med Pulm Drug Deliv 22: 229-237, 2009.
27. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DW. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 151: 1075-1082, 1995.
28. Larsen GL, Holt PG. The concept of airway inflammation. Am J Respir Crit Care Med 162: S2-S6, 2000.
29. Linnane BM, Hall GL, Nolan G, Brennan S, Stick SM, Sly PD, Robertson CF, Robinson PJ, Franklin PJ, Turner SW, Ranganathan SC, AREST-CF. Lung function in infants with cystic fibrosis diagnosed by newborn screening. Am J Respir Crit Care Med 178: 1238-1244, 2008.
30. Lommatzsch M, Cicko S, Muller T, Lucattelli M, Bratke K, Stoll P, Grimm M, Durk T, Zissel G, Ferrari D, Di Virgilio F, Sorichter S, Lungarella G, Virchow JC, Idzko M. Extracellular adenosine triphosphate and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181: 928-934, 2010.
31. Loughlin CE, Esther CR Jr, Lazarowski ER, Alexis NE, Peden DB. Neutrophilic inflammation is associated with altered airway hydration in stable asthmatics. Respir Med 104: 29-33, 2009.
32. Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med 175: 822-828, 2007.
33. Mohsenin A, Blackburn MR. Adenosine signaling in asthma and chronic obstructive pulmonary disease. Curr Opin Pulm Med 12: 54-59, 2006.
34. Okada SF, Nicholas RA, Kreda SM, Lazarowski ER, Boucher RC. Physiological regulation of ATP release at the apical surface of human airway epithelia. J Biol Chem 281: 22992-23002, 2006.
35. Ordonez CL, Kartashov AI, Wohl ME. Variability of markers of inflammation and infection in induced sputum in children with cystic fibrosis. J Pediatr 145: 689-692, 2004.
36. Quittner AL, Buu A, Messer MA, Modi AC, Watrous M. Development and validation of The Cystic Fibrosis Questionnaire in the United States: a health-related quality-of-life measure for cystic fibrosis. Chest 128: 2347-2354, 2005.
37. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr 132: 589-595, 1998.
38. Rowe SM, Miller S, Sorscher EJ. Cystic fibrosis. N Engl J Med 352: 1992-2001, 2005.
39. Sagel SD. Noninvasive biomarkers of airway inflammation in cystic fibrosis. Curr Opin Pulm Med 9: 516-521, 2003.
40. Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 4: 406-417, 2007.
41. Sly PD, Brennan S, Gangell C, de Klerk N, Murray C, Mott L, Stick SM, Robinson PJ, Robertson CF, Ranganathan SC, Australian Respiratory Early Surveillance Team for Cystic Fibrosis (AREST-CF). Lung disease at diagnosis in infants with cystic fibrosis detected by newborn screening. Am J Respir Crit Care Med 180: 146-152, 2009.
42. Vass G, Horvath I. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. Curr Med Chem 15: 917-922, 2008.